NCT06700408View on ClinicalTrials.gov

RCT for the Chinese Medicine in Treating Hypercholesterolemia

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

April 30, 2027

Conditions
Hypercholesterolemia
Interventions
DRUG

Dachaihu Decoction combined Erzhiwan with variation

Chinese medicine granules

OTHER

Placebo granules

Placebo granules

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER